CTOR stock

Citius Oncology, Inc. (CTOR) support and resistance · $105.2M cap

Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.

This page maps Citius Oncology, Inc. (CTOR) support and resistance from cached range and valuation — not a live tape and not a trade alert.

CTOR income-statement cache is thin, so levels here lean on the stock page until the next filing lands.

CTOR currently screens at market cap $105.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.

A new CTOR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.

Not investment advice. Use the CTOR quote page for the session range and the stock page for the full model.

Not investment advice.

Full CTOR analysis